Madalena Energy (MVN) Stock Price, News & Analysis

Company Overview

Madalena Energy Inc. explores for, develops, and produces crude oil, natural gas liquids, and natural gas. It primarily holds interest in the Surubi Block covering an area of 90,824 acres located in the Northwest Basin, Argentina; Puesto Morales Block that covers an area of 59,671 acres located in the Neuquén Basin, Argentina; and Coiron Amargo Norte concession located in the Neuquén Basin of Argentina. The company was formerly known as Madalena Ventures Inc. and changed its name to Madalena Energy Inc. in August 2013. Madalena Energy Inc. is headquartered in Buenos Aires, Argentina.

Key Stats

• Today's Range: C$0.08 to C$0.08
• 50-Day Range: C$0.08 to C$0.08
• 52-Week Range: C$0.08 to C$0.21
• Volume: 111,000 shs
• Average Volume: 114,547 shs
• Market Capitalization: C$43.52 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MVN Stock Analysis - Frequently Asked Questions

How have MVN shares performed this year?

Madalena Energy's stock was trading at C$0.08 at the beginning of the year. Since then, MVN shares have increased by 0.0% and is now trading at C$0.08.
View the best growth stocks for 2024 here.

How do I buy shares of Madalena Energy?

Shares of MVN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Madalena Energy own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Madalena Energy investors own include Fate Therapeutics (FATE), Pluristem Therapeutics (PSTI), YPF Sociedad Anónima (YPF), Lexicon Pharmaceuticals (LXRX), Bellicum Pharmaceuticals (BLCM), Akebia Therapeutics (AKBA) and Array Technologies (ARRY).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Oils/Energy
• Industry: Oil & Gas E & P
• Sub-Industry: N/A
• Current Symbol: CVE:MVN
• CUSIP: N/A
• CIK: N/A
• Web: www.madalena-ventures.com
• Phone: +1-403-2621901
• Fax: N/A
• Employees: 93
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 17.24
• Current Ratio: 0.84
• Quick Ratio: 0.53

Sales & Book Value

• Annual Sales: C$28.29 million
• Price / Sales: 1.54
• Cash Flow: C$0.00 per share
• Price / Cash Flow: 30.00
• Book Value: C$0.06 per share
• Price / Book: 1.33

Miscellaneous

• Outstanding Shares: 544,060,000
• Free Float: N/A
• Market Cap: C$43.52 million
• Optionable: Not Optionable
• Beta: N/A